Global Non-Surgical Cosmetic Facial Product Market Growth (Status and Outlook) 2025-2031

The global Non-Surgical Cosmetic Facial Product market size is predicted to grow from US$ 19320 million in 2025 to US$ 35530 million in 2031; it is expected to grow at a CAGR of 10.7% from 2025 to 2031.

Non-surgical cosmetic facial procedures refer to a range of aesthetic treatments that can enhance or rejuvenate the appearance of the face without the need for surgery. These procedures have gained popularity due to their non-invasive nature, minimal downtime, and ability to provide noticeable results.

United States market for Non-Surgical Cosmetic Facial Product is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Non-Surgical Cosmetic Facial Product is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Non-Surgical Cosmetic Facial Product is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Non-Surgical Cosmetic Facial Product players cover AbbVie, Galderma, LG Life Sciences, Merz, Medytox, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Non-Surgical Cosmetic Facial Product Industry Forecast” looks at past sales and reviews total world Non-Surgical Cosmetic Facial Product sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-Surgical Cosmetic Facial Product sales for 2025 through 2031. With Non-Surgical Cosmetic Facial Product sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Surgical Cosmetic Facial Product industry.

This Insight Report provides a comprehensive analysis of the global Non-Surgical Cosmetic Facial Product landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Non-Surgical Cosmetic Facial Product portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-Surgical Cosmetic Facial Product market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Surgical Cosmetic Facial Product and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Surgical Cosmetic Facial Product.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-Surgical Cosmetic Facial Product market by product type, application, key players and key regions and countries.

Segmentation by Type:

Dermal Fillers

Botulinum Toxin

Other

Segmentation by Application:

Hospital

Beauty Salon

Other

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

AbbVie

Galderma

LG Life Sciences

Merz

Medytox

Hugel

Croma-Pharma

Beijing IMEIK

Bloomage Bio

Elravie (Humedix)

Cleviel (Pharma Research Products)

Haohai Biological

Teoxane

Sinclair

Suneva Medical

CG Bio

SciVision Biotech

Prollenium

Bohus BioTech

Caregen

Ipsen

LIBP

US World Meds

Daewoong

JETEMA

Please note: The report will take approximately 2 business days to prepare and deliver.